Osta Biotechnologies Inc. is a biopharmaceutical company. Its principal business is to carry out research and development work for the development of therapeutic products specific to cancer, Alzheimer’s disease, X-linked hypophosphatemia (XLH) and osteoporosis. The Company is a life sciences company focused on the development of therapeutic products for Cancer and Alzheimer's disease. Its wholly owned subsidiary includes Osta Biopharma Inc. (Osta). As of December 31, 2010, it did not have any products that are at the commercialization stage.